| Name | 2-[(2S)-4-methyl-3-oxo-7-(4-piperidin-4-ylpiperidine-1-carbonyl)-2,5-dihydro-1H-1,4-benzodiazepin-2-yl]acetic acid |
|---|---|
| Synonyms | Lotrafiban |
| Description | Lotrafiban is an orally-active platelet GPIIb/IIIa blocker for treatment of coronary and cerebrovascular disease. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.22g/cm3 |
|---|---|
| Boiling Point | 730ºC at 760 mmHg |
| Molecular Formula | C23H32N4O4 |
| Molecular Weight | 428.52500 |
| Flash Point | 395.3ºC |
| Exact Mass | 428.24200 |
| PSA | 101.98000 |
| LogP | 2.10820 |
| Vapour Pressure | 2.27E-22mmHg at 25°C |
| Index of Refraction | 1.572 |